Nuvation Bio Stock Analysis

NUVB Stock  USD 3.05  0.02  0.66%   
Nuvation Bio is undervalued with Real Value of 3.63 and Target Price of 4.08. The main objective of Nuvation Bio stock analysis is to determine its intrinsic value, which is an estimate of what Nuvation Bio is worth, separate from its market price. There are two main types of Nuvation Bio's stock analysis: fundamental analysis and technical analysis.
The Nuvation Bio stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nuvation Bio's ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.

Nuvation Stock Analysis Notes

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nuvation Bio recorded a loss per share of 0.32. The entity had not issued any dividends in recent years. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people. To find out more about Nuvation Bio contact David Hung at 332 208 6102 or learn more at

Nuvation Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nuvation Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nuvation Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nuvation Bio is way too risky over 90 days horizon
Nuvation Bio appears to be risky and price may revert if volatility continues
Net Loss for the year was (75.8 M) with profit before overhead, payroll, taxes, and interest of 0.
Nuvation Bio currently holds about 703.8 M in cash with (68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Nuvation Bio has a frail financial position based on the latest SEC disclosures
Roughly 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Institutional investors control 42 percent of Nuvation Bio Inc. and were rewarded last week after stock increased 11

Nuvation Bio Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nuvation Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of March 2024
Upcoming Quarterly Report
2nd of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
20th of March 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Nuvation Largest EPS Surprises

Earnings surprises can significantly impact Nuvation Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Nuvation Bio Environmental, Social, and Governance (ESG) Scores

Nuvation Bio's ESG score is a quantitative measure that evaluates Nuvation Bio's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Nuvation Bio's operations that may have significant financial implications and affect Nuvation Bio's stock price as well as guide investors towards more socially responsible investments.

Nuvation Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 756.92 M.

Nuvation Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.16)(0.17)
Return On Assets(0.12)(0.13)
Return On Equity(0.13)(0.13)

Management Efficiency

Nuvation Bio has return on total asset (ROA) of (0.092) % which means that it has lost $0.092 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1115) %, meaning that it created substantial loss on money invested by shareholders. Nuvation Bio's management efficiency ratios could be used to measure how well Nuvation Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of June 23, 2024, Return On Tangible Assets is expected to decline to -0.13. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Nuvation Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.4 M, whereas Total Current Assets are forecasted to decline to about 439.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.76  1.98 
Tangible Book Value Per Share 2.76  1.98 
Enterprise Value Over EBITDA(2.93)(3.08)
Price Book Value Ratio 0.55  0.52 
Enterprise Value Multiple(2.93)(3.08)
Price Fair Value 0.55  0.52 
The analysis of Nuvation Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Nuvation Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Nuvation Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Return On Assets
Return On Equity

Technical Drivers

As of the 23rd of June, Nuvation Bio secures the Risk Adjusted Performance of 0.0886, mean deviation of 4.44, and Downside Deviation of 4.46. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvation Bio, as well as the relationship between them.

Nuvation Bio Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nuvation Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nuvation Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Nuvation Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuvation Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuvation Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuvation Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nuvation Bio Predictive Daily Indicators

Nuvation Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nuvation Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nuvation Bio Corporate Filings

20th of June 2024
An amendment to a previously filed Form 8-K
13th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
29th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
24th of May 2024
Other Reports
14th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
26th of April 2024
An amendment to a previously filed Form 10-K
18th of April 2024
Other Reports
11th of April 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock

Nuvation Bio Forecast Models

Nuvation Bio's time-series forecasting models are one of many Nuvation Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuvation Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Nuvation Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvation Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nuvation Bio. By using and applying Nuvation Stock analysis, traders can create a robust methodology for identifying Nuvation entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Nuvation Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nuvation analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nuvation analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.08Strong Buy6Odds
Nuvation Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Nuvation analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nuvation stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nuvation Bio, talking to its executives and customers, or listening to Nuvation conference calls.
Nuvation Analyst Advice Details

Nuvation Stock Analysis Indicators

Nuvation Bio stock analysis indicators help investors evaluate how Nuvation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nuvation Bio shares will generate the highest return on investment. By understating and applying Nuvation Bio stock analysis, traders can identify Nuvation Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow101.1 M
Common Stock Shares Outstanding218.9 M
Total Stockholder Equity605.1 M
Property Plant And Equipment Net4.3 M
Cash And Short Term Investments611.2 M
Cash42.6 M
Accounts Payable2.2 M
Net Debt-38.6 M
50 Day M A3.0038
Total Current Liabilities14 M
Other Operating Expenses99.8 M
Non Current Assets TotalM
Non Currrent Assets Other728 K
Stock Based Compensation19.5 M

Complementary Tools for Nuvation Stock analysis

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume